Contact Us

ICHGCP.net offers rectangle, banner and skyscraper ads. We have more than 800,000 page views served and more than 500,000 unique users each month. For information, ad rates, and inquiries about advertising contact us on [email protected].

 

DISCLAIMER:

Please note that this is not The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) official website. Though we are committed to posting updated information on the GCP principles from all over the world, we do not guarantee its correctness or state-of-the-art.

If you seek official comments on GCP or other clinical trials related questions, please forward your requests to the official website of your country.

Clinical Research News

ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma
The study of the DO-2 drug in patients with advanced or refractory solid tumours
Study to compare AT278 with standard insulin aspart NovoRapid® in participants with Type 2 Diabetes

Upcoming Clinical Trials

Clinical Research Jobs

Sponsors and Collaborators

Medical Conditions

Drug Interventions